BR112022019202A2 - Oligopeptídeo, composição farmacêutica, composição, e, método para reduzir a inflamação intestinal em um ser humano, para promover crescimento em um animal e para realçar conversão de alimento em um animal - Google Patents
Oligopeptídeo, composição farmacêutica, composição, e, método para reduzir a inflamação intestinal em um ser humano, para promover crescimento em um animal e para realçar conversão de alimento em um animalInfo
- Publication number
- BR112022019202A2 BR112022019202A2 BR112022019202A BR112022019202A BR112022019202A2 BR 112022019202 A2 BR112022019202 A2 BR 112022019202A2 BR 112022019202 A BR112022019202 A BR 112022019202A BR 112022019202 A BR112022019202 A BR 112022019202A BR 112022019202 A2 BR112022019202 A2 BR 112022019202A2
- Authority
- BR
- Brazil
- Prior art keywords
- animal
- composition
- oligopeptide
- promoting growth
- human
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 241001465754 Metazoa Species 0.000 title abstract 3
- 108010038807 Oligopeptides Proteins 0.000 title abstract 3
- 102000015636 Oligopeptides Human genes 0.000 title abstract 3
- 206010061218 Inflammation Diseases 0.000 title abstract 2
- 238000006243 chemical reaction Methods 0.000 title abstract 2
- 230000004054 inflammatory process Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000001737 promoting effect Effects 0.000 title abstract 2
- 230000000968 intestinal effect Effects 0.000 title 1
- BSOQXXWZTUDTEL-ZUYCGGNHSA-N muramyl dipeptide Chemical compound OC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]1NC(C)=O BSOQXXWZTUDTEL-ZUYCGGNHSA-N 0.000 abstract 3
- 108010042708 Acetylmuramyl-Alanyl-Isoglutamine Proteins 0.000 abstract 2
- 108010016626 Dipeptides Proteins 0.000 abstract 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 abstract 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 abstract 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 abstract 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 1
- 229950006780 n-acetylglucosamine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/5555—Muramyl dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063000364P | 2020-03-26 | 2020-03-26 | |
| PCT/US2021/024142 WO2021195372A1 (en) | 2020-03-26 | 2021-03-25 | Lipophilic enantiomers of desacetylglucosamine muramyl dipeptide with anti-inflammatory and growth promoting activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022019202A2 true BR112022019202A2 (pt) | 2022-11-08 |
Family
ID=77892334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022019202A BR112022019202A2 (pt) | 2020-03-26 | 2021-03-25 | Oligopeptídeo, composição farmacêutica, composição, e, método para reduzir a inflamação intestinal em um ser humano, para promover crescimento em um animal e para realçar conversão de alimento em um animal |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12492222B2 (enExample) |
| EP (1) | EP4126040B1 (enExample) |
| JP (1) | JP7667177B2 (enExample) |
| KR (1) | KR102897673B1 (enExample) |
| CN (1) | CN115605226A (enExample) |
| AU (1) | AU2021241625B2 (enExample) |
| BR (1) | BR112022019202A2 (enExample) |
| CA (1) | CA3172936A1 (enExample) |
| ES (1) | ES3014076T3 (enExample) |
| MX (1) | MX2022011751A (enExample) |
| PL (1) | PL4126040T3 (enExample) |
| WO (1) | WO2021195372A1 (enExample) |
| ZA (1) | ZA202210586B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3929293A3 (en) | 2015-04-03 | 2022-03-16 | University Of Massachusetts | Fully stabilized asymmetric sirna |
| WO2017030973A1 (en) | 2015-08-14 | 2017-02-23 | University Of Massachusetts | Bioactive conjugates for oligonucleotide delivery |
| WO2017132669A1 (en) | 2016-01-31 | 2017-08-03 | University Of Massachusetts | Branched oligonucleotides |
| WO2018237245A1 (en) | 2017-06-23 | 2018-12-27 | University Of Massachusetts | TWO TAIL SELF-ADMINISTRATION SIRNA AND ASSOCIATED METHODS |
| BR112021002440A2 (pt) | 2018-08-10 | 2021-05-04 | University Of Massachusetts | oligonucleotídeos modificados visando snps |
| WO2020041769A1 (en) | 2018-08-23 | 2020-02-27 | University Of Massachusetts | O-methyl rich fully stabilized oligonucleotides |
| CN113614232A (zh) | 2019-01-18 | 2021-11-05 | 马萨诸塞大学 | 动态药代动力学修饰锚 |
| EP3946369A4 (en) | 2019-03-26 | 2023-10-18 | University Of Massachusetts | MODIFIED OLIGONUCLEOTIDES WITH INCREASED STABILITY |
| KR20220047989A (ko) | 2019-08-09 | 2022-04-19 | 유니버시티 오브 매사추세츠 | Snp를 표적화하는 화학적으로 변형된 올리고뉴클레오타이드 |
| US12365894B2 (en) | 2019-09-16 | 2025-07-22 | University Of Massachusetts | Branched lipid conjugates of siRNA for specific tissue delivery |
| AU2021244600A1 (en) | 2020-03-26 | 2022-11-03 | University Of Massachusetts | Synthesis of modified oligonucleotides with increased stability |
| CN115605226A (zh) | 2020-03-26 | 2023-01-13 | 纽特莱特公司（Us） | 具有抗炎和生长促进活性的去乙酰基葡糖胺胞壁酰二肽的亲脂对映异构体 |
| CA3174079A1 (en) | 2020-05-26 | 2021-12-02 | Anastasia Khvorova | Synthetic oligonucleotides having regions of block and cluster modifications |
| WO2024102639A1 (en) * | 2022-11-08 | 2024-05-16 | The Scripps Research Institute | N-arylpyrazole nod2 agonists as promoters of immune checkpoint inhibitor therapy |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2428051A1 (fr) * | 1978-06-05 | 1980-01-04 | Anvar | Nouveaux composes du type muramyl-peptide et medicaments les contenant |
| SI9011830B (sl) | 1990-09-27 | 1999-12-31 | Univerza V Ljubljani, Fakulteta Za Farmacijo | Novi N-acildipeptidi, postopki za njihovo pripravo in farmacevtski pripravki, ki jih vsebujejo |
| JPH0655107B2 (ja) | 1991-03-13 | 1994-07-27 | 全国農業協同組合連合会 | 家畜，家禽，および魚介類用の抗仮性狂犬病ならびに抗病性飼料および飼料用添加物 |
| WO1993013791A1 (en) | 1992-01-20 | 1993-07-22 | Peptech (Uk) Limited | Use of muramyl peptides for enhancing animal production |
| MX9301789A (es) | 1992-04-03 | 1993-10-01 | Iaf Biochem Int | Nuevos oligopeptidos lipofilicos con actividad inmunomoduladora. |
| CN1162920A (zh) * | 1994-09-21 | 1997-10-22 | 英国佩普技术有限公司 | 胞壁酰肽化合物的应用 |
| US5976580A (en) | 1995-06-07 | 1999-11-02 | Novus International, Inc. | Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals |
| GB9618673D0 (en) * | 1996-09-06 | 1996-10-16 | Peptech Uk Ltd | The use of muramyl peptides |
| RU2375047C2 (ru) | 2004-03-26 | 2009-12-10 | Лек Фармасьютиклз Д.Д. | Фармацевтическая лекарственная форма, устойчивая к действию желудочного сока, включающая n-(2-(2-фталимидоэтокси)ацетил)-l-аланил-d-глутаминовую кислоту (lk 423) |
| CA2666814A1 (en) | 2006-08-21 | 2008-05-29 | United Therapeutics Corporation | Combination therapy for treatment of viral infections |
| WO2008070564A1 (en) | 2006-12-01 | 2008-06-12 | The Government Of The U.S.A, As Represented By The Secretary, Departmentof Health And Human Services | Uses of muramyl dipeptide (mdp) for treating inflammation |
| KR20100059863A (ko) | 2007-09-11 | 2010-06-04 | 몬도바이오테크 래보래토리즈 아게 | 치료제로서의 펩티드 티모신 베타 ４ 단독 또는 세크로핀 ａ와의 배합물의 용도 |
| CN101918001B (zh) | 2007-12-06 | 2016-11-16 | 英特威国际有限公司 | 使用醋酸美仑孕酮和齐帕特罗或其盐的联合治疗 |
| CN101756026A (zh) | 2008-12-11 | 2010-06-30 | 天津瑞贝特科技发展有限公司 | 增强虾、蟹硬壳速度的营养组合物及其制备方法、应用 |
| DE102009002044A1 (de) | 2009-03-31 | 2010-10-07 | Evonik Degussa Gmbh | Dipeptide als Futtermitteladditive |
| BR112013027845A2 (pt) | 2011-05-18 | 2017-01-03 | Ajinomoto Kk | Imunoestimulante, ração, método para produzir um imunoestimulante, e, método para imunoestimulação |
| CN102578414B (zh) | 2012-02-23 | 2014-01-01 | 青岛绿曼生物工程有限公司 | 促进猪生长育肥、提高免疫力的复方蜂胶饲料添加剂及其制备方法 |
| WO2013172517A1 (ko) | 2012-05-16 | 2013-11-21 | 서울대학교산학협력단 | 뮤라밀-다이펩타이드를 포함하는 골소실 예방, 골재생 또는 골형성 촉진용 약학 조성물 |
| EP2975046A1 (en) * | 2014-07-16 | 2016-01-20 | The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth | Novel compounds |
| WO2017068149A1 (en) | 2015-10-21 | 2017-04-27 | Cysal Gmbh | Aspartyl-dipeptides for aquaculture |
| EP3387005B1 (en) * | 2015-12-10 | 2022-08-24 | Bharat Biotech International Limited | Novel muramyl peptide derivative compound, synthesis and uses thereof |
| CN109562158A (zh) | 2016-06-23 | 2019-04-02 | 纽特莱特公司 | 在动物中促进生长和提高饲料转化率的方法 |
| TWI634902B (zh) * | 2017-10-28 | 2018-09-11 | 醫療財團法人徐元智先生醫藥基金會亞東紀念醫院 | Use of glucosamine peptide compounds for the treatment of abnormal liver metabolism |
| WO2020019128A1 (zh) | 2018-07-23 | 2020-01-30 | 深圳市健元医药科技有限公司 | 丙氨酸—赖氨酸—谷氨酸三肽衍生物及其应用 |
| CN115605226A (zh) | 2020-03-26 | 2023-01-13 | 纽特莱特公司（Us） | 具有抗炎和生长促进活性的去乙酰基葡糖胺胞壁酰二肽的亲脂对映异构体 |
-
2021
- 2021-03-25 CN CN202180038086.5A patent/CN115605226A/zh active Pending
- 2021-03-25 MX MX2022011751A patent/MX2022011751A/es unknown
- 2021-03-25 ES ES21774898T patent/ES3014076T3/es active Active
- 2021-03-25 KR KR1020227036717A patent/KR102897673B1/ko active Active
- 2021-03-25 BR BR112022019202A patent/BR112022019202A2/pt unknown
- 2021-03-25 JP JP2022558084A patent/JP7667177B2/ja active Active
- 2021-03-25 WO PCT/US2021/024142 patent/WO2021195372A1/en not_active Ceased
- 2021-03-25 PL PL21774898.7T patent/PL4126040T3/pl unknown
- 2021-03-25 EP EP21774898.7A patent/EP4126040B1/en active Active
- 2021-03-25 US US17/912,647 patent/US12492222B2/en active Active
- 2021-03-25 AU AU2021241625A patent/AU2021241625B2/en active Active
- 2021-03-25 CA CA3172936A patent/CA3172936A1/en active Pending
-
2022
- 2022-09-23 ZA ZA2022/10586A patent/ZA202210586B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ792610A (en) | 2025-07-25 |
| KR102897673B1 (ko) | 2025-12-09 |
| ZA202210586B (en) | 2023-05-31 |
| JP7667177B2 (ja) | 2025-04-22 |
| AU2021241625B2 (en) | 2025-04-24 |
| AU2021241625A1 (en) | 2022-11-10 |
| JP2023518973A (ja) | 2023-05-09 |
| EP4126040A4 (en) | 2024-04-24 |
| EP4126040A1 (en) | 2023-02-08 |
| US20230174577A1 (en) | 2023-06-08 |
| WO2021195372A1 (en) | 2021-09-30 |
| EP4126040C0 (en) | 2025-02-19 |
| ES3014076T3 (en) | 2025-04-16 |
| PL4126040T3 (pl) | 2025-04-28 |
| KR20220158773A (ko) | 2022-12-01 |
| CA3172936A1 (en) | 2021-09-30 |
| EP4126040B1 (en) | 2025-02-19 |
| CN115605226A (zh) | 2023-01-13 |
| US12492222B2 (en) | 2025-12-09 |
| MX2022011751A (es) | 2022-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112018072064B8 (pt) | Uso de triglicerídeos de cadeia média para preparação de composições nutricionais para proteção cardíaca em animais de estimação | |
| MX2022011751A (es) | Enantiómeros lipofílos de muramil dipéptido desacetilglucosamina con actividad antiinflamatoria y promotora del crecimiento. | |
| DE69114498D1 (de) | Kurzbettige, einfach ungesättigte fettsäuren enthaltende nahrungsmittel und pharmazeutische zusammensetzungen sowie deren anwendungen. | |
| AR003108A1 (es) | Compuestos con propiedades de liberacion de la hormona del crecimiento, composicion farmaceutica que los contienen, el uso de los mismos para la preparación de un medicamento. | |
| AR060247A1 (es) | Oligosacaridos de la leche para estimular el sistema inmune | |
| ES2162586B1 (es) | Composicion que comprende aceites ozonizados y/o otros productos naturales y/o sinteticos ozonizados, y su empleo en composiciones farmaceuticas, cosmeticas, dieteticas o de suplementos alimentarios, en los campos humano y veterinario | |
| CA2260265A1 (fr) | Nouvelle utilisation de phospholipides d'origine animale en therapeutique et/ou dietetique | |
| PT979224E (pt) | Composicoes solidas adequadas para administracao oral compostas por l-carnitina ou alcanoil-l-carnitina fuarato de magnesio | |
| DK0973515T3 (da) | Faste sammensætninger, der er egnet til oral indgivelse, hvilke sammensætninger omfatter et alkanoyl-L-carnitinmagnesiumcitrat | |
| BR112018077032A2 (pt) | método para aprimorar o crescimento ou a conversão alimentar em um animal, uso de pgn, mdp ou um análogo de mdp na preparação de um medicamento e pgn, mdp ou um análogo de mdp | |
| Malone | Managing chronic arthritis | |
| CL2020002800A1 (es) | Composiciones y mètodos para alimentar mamìferos | |
| DE602006011127D1 (de) | Fettsäure-benzenediol-derivate sowie herstellungs- und verwendungsverfahren dafür | |
| ES2186694T3 (es) | Vacuna bacteriana para el tratamiento de necrosis hepatica causada por f. necrophorum. | |
| PT971879E (pt) | Composicoes solidas adequadas para administracao oral compreendendo l-carnitino e alcanoil.l.carnitino tartarato de magnesio | |
| BRPI0419209A2 (pt) | mÉtodo de aumentar a palatabilidade de um produto de raÇço extrusado para animais de estimaÇço, composiÇço intensificadora da palatabilidade para raÇço de animal de estimaÇço extrusada, e, composiÇço de raÇço extrusada para animal de estimaÇço | |
| PT971880E (pt) | Composicoes solidas adequadas para administracao oral compreendendo sais nao-hidroscopicos de l-carnitina e alcanoil-l-carnitina com acido 2-aminoetanossulfonico | |
| BR9808908A (pt) | Composições sólidas adequadas para administração oral que compreendem l-carnitina ou tartarato de alcanoil-l-carnitina colina | |
| MX383324B (es) | Suplemento alimenticio a base de ferulato de etilo | |
| RU2013154562A (ru) | Способы и композиции для сохранения безжировой массы тела в процессе похудения | |
| AR117097A1 (es) | Formulaciones farmacéuticas para una administración subcutánea | |
| RU2008114890A (ru) | Состав, применямый при стрессе у людей и в ветеринарии | |
| PA8567601A1 (es) | Sal agonista del receptor b3-adrenergico, sus formulaciones y sus usos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25D | Requested change of name of applicant approved |
Owner name: NUTRIVERT INC. (US) |